Moreover, IL-6, together with TGF-β, affects the balance between Tregs and Th17 cells, reducing the tumor-suppressive Tregs and promoting the differentiation of pro-inflammatory, Th17 cells (67). Here, TGFB1 is linked to neoplasm.